<DOC>
	<DOCNO>NCT02568735</DOCNO>
	<brief_summary>The main purpose study determine plasma central nervious system pharmacokinetics dexketoprofen etoricoxib . The secondary aim ass effect concentration interleukin 6 , prostaglandin E2 proinflammatory marker plasma cerebrospinal fluid . Thirdly , investigator aim evaluate efficacy postoperative pain treatment .</brief_summary>
	<brief_title>Dexketoprofen Etoricoxib Patients Undergoing Hip Arthroplasty</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Etoricoxib</mesh_term>
	<criteria>agree participate study American Society Anesthesiologist physical status classification 13 elective hip arthroplasty plan contraindication study drug contraindication lumbar puncture refuse participate study age less 40 75 year Planned anesthesia method spinal anesthesia contraindication study drug Contraindications lumbar puncture</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Dexketoprofen</keyword>
	<keyword>Etoricoxib</keyword>
	<keyword>hip arthroplasty</keyword>
	<keyword>pain</keyword>
</DOC>